| BNTX Snapshot | |
|---|---|
| BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany. | |
| VALUATION DATA | |
| Market Capitalization | $20,896,242,000 | Price to Sales | 8.00 |
| Earnings per Share | $4.1000 |
| PE Ratio | 21.15 |
| PRICE DATA | |
| Most Recent Close | $87.2100 |
| 52 Week High | $5.46 |
| 52 Week Low | $0.958 |
| 50-Day Moving Average | $0.871 |
| 200-Day Moving Average | $3.057 |
| All data are from Alpha Vantage as of today. For more infomation on BNTX see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search